Market Cap for Regeneron Pharmaceuticals (REGN)
According to Regeneron Pharmaceuticals's latest reported financial statements, the company's latest reported market cap is $82.98B USD. Market capitalization is the total dollar value of all outstanding shares — shares outstanding × stock price — and the standard measure of a company's equity value. On this page, historical market cap snaps filing-period share counts to closing prices on or before each statement date (not intraday tick data).
Headline figure above is from the reporting period ending (reported ). Chart and table below cover the full reported history back to .
Currently viewingMarket CapSwitch metric
Latest period
$82.98B
YoY change
-11.1%
5Y CAGR
+1.0%
Peak year (2023)
$99.86B
Latest annual
$74.54B
Market Cap history chart for Regeneron Pharmaceuticals (REGN) from 1991 to 2026
Market Cap history table for Regeneron Pharmaceuticals (REGN) from 1991 to 2026
| Fiscal year | Period ended | Reported | Market Cap | YoY |
|---|---|---|---|---|
| 2026 | $74.54B | -11.1% | ||
| 2025 | $83.83B | +2.2% | ||
| 2024 | $81.99B | -17.9% | ||
| 2023 | $99.86B | +21.9% | ||
| 2022 | $81.89B | +15.6% | ||
| 2021 | $70.86B | +27.4% | ||
| 2020 | $55.61B | +29.2% | ||
| 2019 | $43.03B | +0.4% | ||
| 2018 | $42.88B | -1.6% | ||
| 2017 | $43.58B | +2.1% | ||
| 2016 | $42.69B | -31.8% | ||
| 2015 | $62.55B | +34.4% | ||
| 2014 | $46.55B | +52.0% | ||
| 2013 | $30.63B | +55.2% | ||
| 2012 | $19.74B | +293.0% | ||
| 2011 | $5.02B | +84.5% | ||
| 2010 | $2.72B | +41.1% | ||
| 2009 | $1.93B | +33.3% | ||
| 2008 | $1.45B | -9.7% | ||
| 2007 | $1.60B | +37.7% | ||
| 2006 | $1.16B | +30.8% | ||
| 2005 | $889.61M | +72.0% | ||
| 2004 | $517.34M | -30.3% | ||
| 2003 | $742.12M | -8.8% | ||
| 2002 | $813.50M | -31.4% | ||
| 2001 | $1.19B | -4.5% | ||
| 2000 | $1.24B | +209.4% | ||
| 1999 | $400.98M | +75.3% | ||
| 1998 | $228.78M | -7.8% | ||
| 1997 | $248.24M | -37.1% | ||
| 1996 | $394.60M | +56.7% | ||
| 1995 | $251.79M | +342.9% | ||
| 1994 | $56.85M | -77.8% | ||
| 1993 | $256.62M | +38.8% | ||
| 1992 | $184.84M | -34.3% | ||
| 1991 | $281.33M | — |
Market Cap values are taken from Regeneron Pharmaceuticals's reported income statements (10-Q quarterly and 10-K annual filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the date the filing was reported; YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
Analysis
The 2026 reading of Regeneron Pharmaceuticals (REGN) market cap is $74.54B – declined 11.1% year-over-year.
Regeneron Pharmaceuticals market cap has recorded the values shown across consecutive periods, with a +1.0% compound annual growth rate over 2021–2026 (5 years).
Between 2023 and 2026, Regeneron Pharmaceuticals market cap declined 25.4%, falling from $99.86B to $74.54B.
Across the available history, market cap reached its high of $99.86B in 2023 and its low of $56.85M in 1994.
Within Healthcare, Regeneron Pharmaceuticals (REGN) ranks 9th among 8 peers we track. The peer median for market cap is $311.16B.
Regeneron Pharmaceuticals Market Cap by Year
Regeneron Pharmaceuticals Market Cap 2026: $74.54B
Regeneron Pharmaceuticals market cap in 2026 was $74.54B, declined 11.1% below 2025.
Regeneron Pharmaceuticals Market Cap 2025: $83.83B
Regeneron Pharmaceuticals market cap in 2025 was $83.83B, edged up 2.2% from 2024.
Regeneron Pharmaceuticals Market Cap 2024: $81.99B
Regeneron Pharmaceuticals market cap in 2024 was $81.99B, declined 17.9% below 2023.
Regeneron Pharmaceuticals Market Cap 2023: $99.86B
Regeneron Pharmaceuticals market cap in 2023 was $99.86B, grew 21.9% from 2022. This figure represents the highest annual value in the available history.
Regeneron Pharmaceuticals Market Cap 2022: $81.89B
Regeneron Pharmaceuticals market cap in 2022 was $81.89B.
See more financial history for Regeneron Pharmaceuticals (REGN).
Sector peers — Market Cap
Companies in the same sector as Regeneron Pharmaceuticals, ranked by their latest market cap.
| Company | Market Cap | Sector |
|---|---|---|
| Eli Lilly and Company (LLY) | $825.77B | Healthcare |
| Johnson & Johnson (JNJ) | $548.34B | Healthcare |
| AbbVie Inc. (ABBV) | $349.67B | Healthcare |
| UnitedHealth Group Incorporated (UNH) | $332.91B | Healthcare |
| AstraZeneca PLC (AZN) | $289.41B | Healthcare |
| Merck & Co., Inc. (MRK) | $272.11B | Healthcare |
| Amgen Inc. (AMGN) | $183.05B | Healthcare |
| Novo Nordisk A/S (NVO) | $182.96B | Healthcare |
Frequently asked questions
What is Regeneron Pharmaceuticals's market cap?
- Latest reported market cap for Regeneron Pharmaceuticals (REGN) is $82.98B (period ending December 31, 2025).
How has Regeneron Pharmaceuticals market cap changed year-over-year?
- Regeneron Pharmaceuticals (REGN) market cap changed -11.1% year-over-year on the latest annual filing.
What is the long-term growth rate of Regeneron Pharmaceuticals market cap?
- Regeneron Pharmaceuticals (REGN) market cap compound annual growth rate is +1.0% over the most recent 5 years available.
When did Regeneron Pharmaceuticals market cap hit its highest annual value?
- Regeneron Pharmaceuticals market cap reached its highest annual value of $99.86B in 2023.
What was Regeneron Pharmaceuticals market cap in 2025?
- Regeneron Pharmaceuticals (REGN) market cap in 2025 was $83.83B.
What was Regeneron Pharmaceuticals market cap in 2026?
- Regeneron Pharmaceuticals (REGN) market cap in 2026 was $74.54B.
Metrics overview
Pick a metric for charts, filings, and peers — each row shows the latest TTM or annual value with year-over-year change.
Explore more
REGN Overview
Company profile, financial tools, and key metrics
REGN Revenue Counter
Earns $454.81 every second. See per minute, hour, and day.
REGN Earnings Counter
Earns $142.85 per second net profit. See per minute, hour, and day.
REGN Economic Scale
Exceeds Rwanda's GDP. Compare with world economies.
REGN What If Invested
What if you had invested $1,000? See historical returns from any date.
REGN How It Makes Money
Discover visual breakdown of $14.34B in revenue — where it comes from and where it goes.
REGN Stock Seasonality
Best and worst months to invest. Historical monthly returns heatmap.
REGN Price Target Scenarios
Model bear, base, and bull cases with EPS growth and exit P/E — pre-filled from analysts and history.
REGN Daily Price Character
Explosive · 47.1% historical win rate (green days). Streaks & record days.
REGN Buybacks
4.33% TTM buyback yield. Shareholder yield & SBC comparison.
REGN Dividend Profile
Yield: 0.52%. See full history.
REGN Dividend Calculator
How much dividend income would $1,000 have earned? Calculate from any date.
REGN Dividend Forecast
Project future income with DRIP, growth assumptions, and optional monthly contributions.